Today’s Trade Alerts include: Industrial Biotechnology Corp. (Pink Sheets: IBOT), Powerwave Technologies Inc. (Nasdaq: PWAV), Extreme Networks Inc. (Nasdaq: EXTR), Citizens Republic Bancorp Inc. (Nasdaq: CRBC), ImmunoGen Inc. (Nasdaq: IMGN) and Thorium Power Ltd. (OTCBB: THPW).
“Industrial Biotechnology Corp. (IBOT) shares jumped to a 5% increase to $1.14 just after Monday’s opening bell. Industrial Biotechnology provides products, services and technologies using renewable resources as an alternative to petroleum and traditional manufacturing methods...
“Industrial Biotechnology recently introduced the Ethanol Chemicals ALCHEMx Production Platforms. This proprietary process integrates technologies, manufacturing methods and distribution to produce eco-efficient and cost effective chemicals utilizing renewable resources as an alternative to petroleum. This sustainable solution meets global demand to reduce global warming and decrease dependence on foreign oil…
“Renewable Chemicals Corp., a subsidiary of Industrial Biotechnology, will use the ALCHEMx Production Platforms to convert sugarcane based ethanol to ethylene. The bio-ethylene can then be converted into various downstream chemicals including ethylene oxide, low density and high density polyethylene, styrene, and polystyrene. Existing manufacturing infrastructure can be utilized that now produce these same chemicals from petroleum based ethylene....”
“Powerwave Technologies Inc. (PWAV) retreated from Friday’s 11% Monday morning, slipping less than 1% to $4.55 at the opening bell Monday. Last weeks hike comes after the company reported a narrowed second-quarter loss, and adjusted results beat Wall Street's expectations. Powerwave supplies wireless solutions for wireless communications networks worldwide…
“Powerwave reported a second-quarter loss of $10.2 million, or 8 cents per share, compared with a loss of $44.5 million, or 34 cents per share, in the year-ago quarter. Revenue climbed 32.3% to $245.6 million from $185.6 million, beating analysts expectations for $227.5 million in revenue…”
Investors can view all of the TraderNotes and investment articles for free by visiting:
http://www.beaconequity.com/m
Join the fastest growing investor community at:
http://www.stocknetworkonline.com/
BeaconEquity.com’s Market News is one of the fastest growing small cap blogs in the investment community. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting: http://www.BeaconEquity.com/m
BeaconEquity.com is one of the industry’s largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.BeaconEquity.com
Beacon Equity Research Disclosure
The analysts contributing to this report do not hold any shares of Industrial Biotechnology Corp. (Pink Sheets: IBOT). Additionally, the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. The analyst(s) writing this report recognize and aspire to all of the CFA Institute Guidelines for Independent Research. Beacon Equity Research (“Beacon”) certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analysts in the report. Beacon Equity Research and its affiliates have been compensated a total of twenty three thousand dollars from Rovert Consulting for enrollment of IBOT in its research program and other services. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. As such, the report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed herein are subject to change.
Source: BeaconEquity.com
Beacon Equity Research
Jeff Bishop, (469)-252-3505
press@beaconequity.com
